Fecal elastase-1 measures the amount of the digestive enzyme elastase produced by the pancreas. It is a reliable marker for exocrine pancreatic function.
Pankreaselastase im Stuhl should not be read as an isolated number only. This short overview summarizes when the marker matters, which questions it does not answer on its own, and what broader context makes the result more useful.
Pankreaselastase im Stuhl is most useful when it is interpreted together with the symptom pattern, the relevant category context, and the broader diagnostic question behind the test.
Pankreaselastase im Stuhl does not replace symptom timing, functional assessment, or the wider clinical picture. A marker may be informative without being the whole answer.
The next useful step is usually to connect Pankreaselastase im Stuhl to related markers, symptoms, and the broader context of the test rather than reading it as an isolated endpoint.
Fecal elastase-1, also known as pancreatic elastase, is an enzyme secreted by the pancreas that plays a key role in digesting proteins in the small intestine. Unlike other pancreatic enzymes, elastase-1 remains relatively stable during intestinal passage, so its concentration in stool reflects the pancreas's ability to produce digestive enzymes. Measurement of fecal elastase-1 is a noninvasive test used to assess exocrine pancreatic function. Low levels may suggest insufficient enzyme production, which can lead to maldigestion and nutrient malabsorption.
A fecal elastase-1 level below 200 µg/g (lab-dependent) may indicate exocrine pancreatic insufficiency (EPI). Values between 100 and 200 µg/g suggest mild to moderate insufficiency, while values below 100 µg/g often point to severe EPI. This can result from chronic pancreatitis, cystic fibrosis, pancreatic cancer, or other conditions that damage the pancreas. Low levels may lead to digestive symptoms like fatty stools, weight loss, and nutrient deficiencies.
High fecal elastase-1 levels, generally above 500 µg/g, are considered normal and indicate robust pancreatic enzyme production. There is no recognized upper limit for concern in clinical practice. In rare cases, extremely elevated values might be seen in early acute pancreatitis, but this test is not designed to diagnose acute conditions.
This result is not specific for ME/CFS or Long COVID. Read it together with the clinical question, symptoms, related findings and the laboratory reference range rather than in isolation.
Practical details are separated from the general FAQ so they are easier to find.
The test requires a small stool sample, which can be collected at home. It is important to avoid liquid or diarrheal stools because they can dilute the sample and falsely lower the result. The sample is then sent to a laboratory for analysis.
Pankreaselastase im Stuhl is most useful when it is interpreted together with the symptom pattern, the relevant category context, and the broader diagnostic question behind the test.
The next useful step is usually to connect Pankreaselastase im Stuhl to related markers, symptoms, and the broader context of the test rather than reading it as an isolated endpoint.
You now know which questions can matter when reading this result. With Elara you can keep the value and its surrounding context together over time.
Save the lab value with its date so individual measurements do not get lost.
See previous measurements together instead of relying on a single snapshot.
View Fecal Elastase-1 (Pancreatic Elastase, FE-1) alongside symptom, energy, sleep and PEM entries without assuming one caused the other.
Export your history as a PDF — structured for the next check-up.
A normal fecal elastase-1 level is typically above 200 micrograms per gram of stool (µg/g). This threshold is lab-dependent and may vary slightly. Values above 200 µg/g generally indicate adequate exocrine pancreatic function.
A fecal elastase-1 level below 200 µg/g may suggest exocrine pancreatic insufficiency (EPI). Mild to moderate insufficiency is often considered between 100 and 200 µg/g, while severe insufficiency is below 100 µg/g. Low levels can be caused by chronic pancreatitis, cystic fibrosis, pancreatic surgery, or pancreatic cancer. It is important to follow up with a healthcare provider for a full evaluation.
In clinical practice, high fecal elastase-1 levels are not a cause for concern. They reflect good pancreatic function. There is no established upper limit that indicates a problem. An extremely high result may sometimes occur in early acute pancreatitis but this test is not used for that diagnosis.
Pankreaselastase im Stuhl does not replace symptom timing, functional assessment, or the wider clinical picture. A marker may be informative without being the whole answer.
This biomarker gains value when it is connected to symptom patterns, daily function, and structured self-observation instead of being read in isolation.
Reduced capacity, multisystem symptoms, and delayed worsening often make more sense when the broader ME/CFS pattern is considered.
Markers linked to sleep, stress, recovery, hormones, or metabolism often become more useful when viewed through pacing and daily load management.
Questionnaires help connect biomarkers to symptom patterns, functional limits, and patient-reported change over time.
Markers from the same system can add useful context when a single lab value is hard to interpret on its own.
No individual medical review is documented.
This English content was created with AI assistance and automatically validated. This is not an individual medical review.
This information does not replace medical advice. Lab values should be assessed in the context of your medical history, the reason for testing and other findings. Elara provides health information for orientation — not diagnoses or treatment decisions.
Bring your lab values, symptoms and energy into one shared context — so you walk into your next appointment more informed and structured.
